176 related articles for article (PubMed ID: 2920482)
1. Role of fluoroquinolones in lower respiratory tract infections.
Vellend H
Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolones in respiratory infections.
Klein NC
Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
[TBL] [Abstract][Full Text] [Related]
3. [Fluoroquinolones: pharmacology, antibacterial spectrum and indications in pneumology].
Underner M; Grignon B; Roblot F; Meurice JC; Patte F
Rev Pneumol Clin; 1989; 45(1):14-22. PubMed ID: 2662344
[TBL] [Abstract][Full Text] [Related]
4. Overview of experience with ofloxacin in respiratory tract infection.
Ball P
Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Pedersen SS
Scand J Infect Dis Suppl; 1989; 60():89-97. PubMed ID: 2667111
[TBL] [Abstract][Full Text] [Related]
7. Emerging resistance problems among respiratory tract pathogens.
Lister PD
Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
Foster MT
Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
[TBL] [Abstract][Full Text] [Related]
9. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
Niederman MS
Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
[TBL] [Abstract][Full Text] [Related]
10. Quinolones in the treatment of bronchopulmonary infections.
Thys JP
Rev Infect Dis; 1988; 10 Suppl 1():S212-7. PubMed ID: 3279495
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
[TBL] [Abstract][Full Text] [Related]
12. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
Fass RJ
Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
Jones RN; Pfaller MA
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
[TBL] [Abstract][Full Text] [Related]
16. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Thys JP; Jacobs F; Byl B
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
[TBL] [Abstract][Full Text] [Related]
17. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
Stein GE; Havlichek DH
Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
[TBL] [Abstract][Full Text] [Related]
18. The place of quinolones in the treatment of respiratory tract infections.
van der Meer JW
Pharm Weekbl Sci; 1989 Aug; 11(4):132-3. PubMed ID: 2677985
[TBL] [Abstract][Full Text] [Related]
19. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Chodosh S
Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic focus. The fluoroquinolones.
James DG
Br J Clin Pract; 1989 Feb; 43(2):66-7. PubMed ID: 2679837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
